Ambrisentan 5 mg tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Ambrisentan 5 mg Tablet is an endothelin receptor antagonist. It is prescribed for pulmonary arterial hypertension (PAH), where it blocks a natural substance that narrows blood vessels, helping to relax the vessels and improve blood flow to the lungs, and is described as helping to slow disease progression and improve quality of life.

Active ingredient
Ambrisentan
Strength
5 mg
Dosage form
Oral tablet
Therapeutic class
Endothelin receptor antagonist
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with ambrisentan and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Treatment of pulmonary arterial hypertension (PAH)
  • Described as improving exercise ability and quality of life and slowing disease progression
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Swallowed whole once daily; not to be chewed, crushed, or broken
  • Taken at a fixed time each day, with or without food
  • Dose and duration are set by the prescriber

Described Side Effects

Commonly described side effects include:

  • Peripheral oedema (swelling of the limbs)
  • Nasal congestion
  • Sinus inflammation (sinusitis)
  • Flushing (a sense of warmth in the face, ears, neck, and trunk)

Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Endothelin receptor antagonists can harm a developing fetus; ambrisentan is not for use in pregnancy, and effective contraception is required per prescribing information
  • Liver function may need monitoring during treatment
  • Extra caution is advised in patients with liver or kidney disease
  • Full medical history should be shared with the prescriber

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling, ambrisentan is an endothelin receptor antagonist used to treat pulmonary arterial hypertension (PAH). SDO Pharma has not independently verified these claims.

Swallowed whole once daily at a fixed time, with or without food, at the dose set by the prescriber.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services